Brief report: clonazepam behavioral side effects with an individual with mental retardation.

Carr et al. (2003) watched one adult with intellectual disability. The person took clonazepam for seizures. Staff counted aggressive and self-harming acts each day. They kept the same dose for weeks, then stopped the drug. They kept counting after the last pill.

When clonazepam left the body, severe problem acts dropped from 3 out of every 100 minutes to 1 out of every 1,000 minutes. That is a 30-fold drop. The change was fast and clear. No other meds were changed at the same time.

Lancioni et al. (2000) saw the same pattern. Five adults with ID cut barbiturate seizure meds. Challenging behavior fell 80 percent and antipsychotic dose also dropped. Both studies show that some seizure drugs can hide as behavior problems.

Matson et al. (2004) looks opposite. They gave phenytoin, another seizure drug, to adults with ID. Social skills got worse, not better. The gap is real: clonazepam and phenytoin act on different brain paths and change different skills.

Hilton et al. (2010) and Deb et al. (2014) both say the same thing: track behavior every time you start, stop, or switch any psychoactive med. The case study gives the vivid example; the reviews give the checklist.

You may see clients whose aggression or SIB starts or spikes after a new clonazepam order. Run a simple A-B plot for one week on the drug and one week off. Share the data with the prescriber. A taper, not an add-on antipsychotic, could be the real fix.